Revenla Tablet, Film Coated
Product Images NDC 87367-166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revenla (NDC 87367-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Insignamedex Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51691df6 5457 3b1b E063 6394a90a0406

FDA Label Image

Dosage Forms And Strength (Sevelamer Carbonate Product Label)

Dosage Forms And Strength (Sevelamer Carbonate Product Label)
This text contains information about a medication with the active ingredient Sevelamer carbonate at a dosage of 800 mg per tablet. The usual dosage instructions are available in the package insert. The tablets should be stored at controlled room temperature (between 59°F to 86°F) and protected from moisture. The medication is intended for prescription use only. The product was manufactured in China for InsignaMedex LLC and the revision date is 05/2026.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.